White House Cancer Support Limited - Charities report - 20.1.6

White House Cancer Support Limited - Charities report - 20.1.6


IRIS Accounts Production v20.1.5.71 Other Company accounts True false Pounds 1.4.19 31.3.20 31.3.20 FY FRS 102 Independent examiner Large and medium-sized companies regime for accounts Full Charities SORP true true true true true false true true false true true iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure076048472019-03-31076048472020-03-31076048472019-04-012020-03-31076048472018-03-31076048472018-04-012019-03-31076048472019-03-3107604847ns22:CharitableCompanyLimitedByGuarantee2019-04-012020-03-3107604847ns15:PoundSterling2019-04-012020-03-3107604847ns11:FRS1022019-04-012020-03-3107604847ns11:IndependentExaminationCharity2019-04-012020-03-3107604847ns11:LargeMedium-sizedCompaniesRegimeForAccounts2019-04-012020-03-3107604847ns11:FullAccounts2019-04-012020-03-3107604847ns11:CharitiesSORP2019-04-012020-03-3107604847ns16:EnglandWales2019-04-012020-03-3107604847ns11:RegisteredOffice2019-04-012020-03-3107604847ns22:Trustee112019-04-012020-03-3107604847ns22:Trustee132019-04-012020-03-3107604847ns22:Trustee142019-04-012020-03-3107604847ns22:Trustee162019-04-012020-03-3107604847ns22:Trustee182019-04-012020-03-3107604847ns22:Trustee192019-04-012020-03-3107604847ns22:Trustee202019-04-012020-03-3107604847ns22:TotalUnrestrictedFunds2019-04-012020-03-3107604847ns22:TotalRestrictedIncomeFunds2019-04-012020-03-3107604847ns22:TotalEndowmentFunds2019-04-012020-03-3107604847ns22:Activity82019-04-012020-03-3107604847ns22:TotalUnrestrictedFundsns22:Activity82019-04-012020-03-3107604847ns22:TotalRestrictedIncomeFundsns22:Activity82019-04-012020-03-3107604847ns22:Activity8ns22:TotalEndowmentFunds2019-04-012020-03-3107604847ns22:Activity82018-04-012019-03-3107604847ns22:TotalUnrestrictedFunds2019-03-3107604847ns22:TotalRestrictedIncomeFunds2019-03-3107604847ns22:TotalEndowmentFunds2019-03-3107604847ns22:TotalUnrestrictedFunds2020-03-3107604847ns22:TotalRestrictedIncomeFunds2020-03-3107604847ns22:TotalEndowmentFunds2020-03-3107604847ns6:WithinOneYearns22:TotalUnrestrictedFunds2020-03-3107604847ns6:WithinOneYearns22:TotalRestrictedIncomeFunds2020-03-3107604847ns6:WithinOneYearns22:TotalEndowmentFunds2020-03-3107604847ns6:WithinOneYear2020-03-3107604847ns6:WithinOneYear2019-03-3107604847ns6:LandBuildingsns6:OwnedOrFreeholdAssets2019-04-012020-03-3107604847ns6:FurnitureFittingsToolsEquipment2019-04-012020-03-3107604847ns6:ComputerEquipment2019-04-012020-03-310760484722019-04-012020-03-310760484732019-04-012020-03-3107604847ns6:OwnedAssets2019-04-012020-03-3107604847ns6:OwnedAssets2018-04-012019-03-3107604847ns22:TotalUnrestrictedFunds2018-04-012019-03-3107604847ns22:TotalRestrictedIncomeFunds2018-04-012019-03-3107604847ns22:TotalEndowmentFunds2018-04-012019-03-3107604847ns22:TotalUnrestrictedFundsns22:Activity82018-04-012019-03-3107604847ns22:TotalRestrictedIncomeFundsns22:Activity82018-04-012019-03-3107604847ns22:Activity8ns22:TotalEndowmentFunds2018-04-012019-03-3107604847ns6:LandBuildingsns6:OwnedOrFreeholdAssets2019-03-3107604847ns6:FurnitureFittings2019-03-3107604847ns6:ComputerEquipment2019-03-3107604847ns6:FurnitureFittings2019-04-012020-03-3107604847ns6:LandBuildingsns6:OwnedOrFreeholdAssets2020-03-3107604847ns6:FurnitureFittings2020-03-3107604847ns6:ComputerEquipment2020-03-3107604847ns6:LandBuildingsns6:OwnedOrFreeholdAssets2019-03-3107604847ns6:FurnitureFittings2019-03-3107604847ns6:ComputerEquipment2019-03-31
REGISTERED COMPANY NUMBER: 07604847 (England and Wales)
REGISTERED CHARITY NUMBER: 1141904














REPORT OF THE TRUSTEES AND

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2020

FOR

WHITE HOUSE CANCER SUPPORT LIMITED

WHITE HOUSE CANCER SUPPORT LIMITED






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2020




Page

Report of the Trustees 1 to 5

Independent Examiner's Report 6

Statement of Financial Activities 7

Balance Sheet 8 to 9

Notes to the Financial Statements 10 to 18

WHITE HOUSE CANCER SUPPORT LIMITED (REGISTERED NUMBER: 07604847)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2020

The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with
the financial statements of the charity for the year ended 31st March 2020. The trustees have adopted the provisions of
Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their
accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)
(effective 1 January 2019).

OBJECTIVES AND ACTIVITIES
Objectives and aims
The objectives of the charity are to relieve cancer patients, their family and friends, through the trauma of the diagnosis
and treatment of cancer by the provision of care and support and to further the knowledge and understanding of cancer.

Significant activities
In planning out activities for the year we kept in mind the Charity Commission's guidance on public benefit at our trustee
meetings.

We are a local charity providing bespoke 1-2-1 practical and emotional support to cancer patients and those who care
for them. Services include home to hospital transport, counselling, complementary therapies, peer support groups, social
activities, and information. All services are delivered by a small number of paid employees and a team of dedicated
volunteers.

Services are available to all cancer patients and those that care for them within the Dudley Metropolitan Borough and it's
surrounding areas.

Volunteers
During the period the charity received help from the following number of people:


20202019

Administration and general1417
Transport2220
Therapy and counselling1820

ACHIEVEMENT AND PERFORMANCE
Charitable activities
The charity continues to receive financial support from Dudley Clinical Commissioning Group. However, this is solely
for the running of the home to hospital transportation service. Funds for additional services and activities are sourced
via public donations and/or through the application of funds from trust and grant-making bodies. Working with other
charities, namely Lymphcare UK and Ovacome, the charity further received income from the rental of space on the
lower ground floor. We are currently in discussions with new tenants to take over the whole of the ground floor once
Lymphcare UK source alternative accommodation. Additionally, income is further received on an ad-hoc basis from the
renting out of space within the building.

Throughout the period the charity has continued to widen its scope and now works in greater partnership with other
charities supporting those affected by a cancer diagnosis and other long-term conditions. Recipients accessing services,
particularly counselling support, have continued to increase throughout the period and to support these increases and
demand for services, additional staff members were recruited with an objective of raising awareness of services and
raising funds to help cover costs.

GDPR and Data Processing

To adhere to all legislation and guidelines the charity's cloud-based customer relationship management database (CRM)
is fully operational and has significantly reduced the need to retain paper based records.


WHITE HOUSE CANCER SUPPORT LIMITED (REGISTERED NUMBER: 07604847)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2020

FINANCIAL REVIEW
Financial position
The charity, along with many other charities in the third sector, continues to operate on a deficit budget. Great efforts
are being made to reduce this deficit, including measures outlined in earlier in the report. We will continue to lobby for
additional funding streams to ensure the sustainability of the charity going forward. We are also very grateful for the
donations from our supporters, without which none of this would be possible.

The results for this year, though disappointing, were not entirely unexpected and are consistent with the deficit in the
previous year. We continue to operate with no core funding from the Local Authority, but we recognise they are also
under pressure. However, our commitment remains to the people in Dudley suffering from life limiting illness to
continue to operate our services at normal levels for as long as we are able.

The funds of the charity at 31 March 2020 were as follows.


£

General Fund (residue) 147,325
Designated Fund (for improvements) 225,000
Restricted Funds (various) 34,233
Endowment Fund -(property) 278,167
684,725


Further details of individual funds is shown in Note 15.

Principal funding sources
Dudley Clinical Commissioning Group, soon to become the Multi-speciality Community Provider (MCP), continues to
award the charity an annual grant, and we have been assured by the MCP commissioning body that this grant will
continue to be provided for the delivery of the home to hospital transport service. We will continue to update the MCP
of all services and the demands placed upon us, particularly with a view to requesting additional financial support.

Investment policy and objectives
The Memorandum & Articles of Association for the charity authorise the trustees to make and hold investments using
general funds of the charity. Accordingly, legacies received in recent years are invested through Brewin Dolphin, based
in Birmingham, on behalf of the charity and its members, and, when judged over the long term. continue to earn higher
returns than would be gained through investing the funds with High Street banks..

Reserves policy
It is board policy to attempt to maintain a cash reserve equivalent to at least a year's potential expenditure.

Going concern
The charity has no potential problems in continuing its activities in, at least, the medium term, and has reserves to meet
and address any contingencies that may occur. However, it is envisaged that the Coronavirus pandemic will cause a
crisis in funding, particularly with a lack of funding from activities and public donations at a time when, due to the virus,
there will be a backlog in cancer treatments and support, ultimately leading to greater demands on all cancer services.

FUTURE PLANS
The charity will continue to extend its area of operation and, according to client demand, will diversify and expand
current service provision. Together with supporting increased demand, the charity has received funds to support the
prevention of cancer agenda and throughout the next financial year will introduce services to support this agenda.
However, the main priority of the charity moving forward will be to secure additional funds to ensure all services
continue and that the sustainability of the charity is guaranteed.


WHITE HOUSE CANCER SUPPORT LIMITED (REGISTERED NUMBER: 07604847)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2020

STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is controlled by its governing document, Articles of Association (amended pursuant to a special resolution
dated 16 September 2014), and constitutes a limited company, limited by guarantee, as defined by the Companies Act
2006.

Recruitment and appointment of new trustees
Trustees are usually appointed by the board during the year, subject to election by the members of the company at the
next Annual General Meeting, and then for a term of three years. Sadly, our recent Chairman, David Westwood, passed
away and further to this, during the period, two trustees retired from the board of trustees. The charity is currently
recruiting new trustees and, with the approval of members will be elected at the next AGM.

Organisational structure
The working names by which the charity is also known are, White House Cancer Support, Cancer Support Dudley,
Dudley Cancer Support and Cancer Support.

Induction and training of new trustees
A Trustee induction pack is available to all new trustees. Throughout their term in office, trustees have the power to
invite potential trustees onto the board, however, all trustees are to be elected by the members at the following Annual
General Meeting.

Key management remuneration
No trustee receives any remuneration, but all professional staff are fully paid and have the opportunity to be included in
the charity pension scheme.

Risk management
The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate
controls are in place to provide reasonable assurance against fraud and error.

The charity continues to purchase insurance for the trustees and officers of the charity against liability arising from
wrongful acts in relation to the charity.

REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
07604847 (England and Wales)

Registered Charity number
1141904

Registered office
The White House
10 Ednam Road
Dudley
West Midlands
DY1 1JX

Trustees
G R Clark (resigned 12/8/19)
Mrs D R Brownlee
D Westwood (deceased 10/10/19)
P Marsh (resigned 26/3/20)
S Henwood
T Langford (resigned 24/4/20)
Mrs T Beese (appointed 19/9/19)


WHITE HOUSE CANCER SUPPORT LIMITED (REGISTERED NUMBER: 07604847)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2020


REFERENCE AND ADMINISTRATIVE DETAILS
Independent Examiner
Worton Rock Limited
Chartered Accountants
Churchfield House
36 Vicar Street
Dudley
West Midlands
DY2 8RG

Bankers
Lloyds Bank PLC
63 High Street
Dudley
West Midlands
DY1 1JX

Solicitors
Higgs & Sons
Waterfront Business Park 3
Brierley Hill
West Midlands
DY5 1LX

Staff

Chief Officer Caroline Webb
Finance Officer Georgina Woods
Transport Officer Jon Rebello
Information and Support Officer Kelly Macchiarelli
Funding Officer Kate Kelly
Communications Officer Katy Warburton
Reception/administration officers Diane Lloyd and Sue Cash

ASSETS HELD AS TRUSTEE FOR OTHERS
The charitable company acts as sole corporate trustee (with trust corporation status) in respect of the White House
Cancer Support Charitable Trust which holds the freehold property known as The White House, 10 Ednam Road,
Dudley, West Midlands, DY1 1JX from which the charitable company operates.

The objects of the White House Cancer Support Charitable Trust are:

- To relieve cancer patients, their families and their friends resident in the Dudley Metropolitan Borough area and
neighbouring areas, of the trauma of the diagnosis and treatment of cancer by the provision of practical help and
emotional support.

- To further the knowledge and understanding of cancer, its treatment and its effects, on the patient and their family and
friends, both clinically and psychologically.

These objects coincide with those of the charitable company.

The property has been included in fixed assets and is accounted for in the reconciliation of funds to represent that the
company controls and manages the property as corporate trustee.


WHITE HOUSE CANCER SUPPORT LIMITED (REGISTERED NUMBER: 07604847)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2020

This report has been prepared in accordance with the special provisions of Part 15 of Companies Act 2006 relating to
small companies.

Approved by order of the board of trustees on 30th July 2020 and signed on its behalf by:





Mrs T Beese - Trustee

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
WHITE HOUSE CANCER SUPPORT LIMITED

Independent examiner's report to the trustees of White House Cancer Support Limited ('the Company')
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31st March 2020.

Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for
the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act
and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried
out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the
Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the
examination giving me cause to believe:

1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any
requirement that the accounts give a true and fair view which is not a matter considered as part of an independent
examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of
Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts
in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should
be drawn in this report in order to enable a proper understanding of the accounts to be reached.








D J Burrows FCA
Institute of Chartered Accountants in England & Wales
Worton Rock Limited
Chartered Accountants
Churchfield House
36 Vicar Street
Dudley
West Midlands
DY2 8RG

30th July 2020

WHITE HOUSE CANCER SUPPORT LIMITED

STATEMENT OF FINANCIAL ACTIVITIES
(INCORPORATING AN INCOME AND EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 31ST MARCH 2020

2020 2019
Unrestricted Restricted Endowment Total Total
funds funds fund funds funds
Notes £    £    £    £    £   
INCOME AND
ENDOWMENTS FROM
Donations and legacies 3 151,366 11,506 - 162,872 118,231

Other trading activities 4 18,520 - - 18,520 36,132
Investment income 5 15,906 - - 15,906 13,707
Total 185,792 11,506 - 197,298 168,070


EXPENDITURE ON
Raising funds 3,065 - - 3,065 4,377

Charitable activities
Social care 240,637 10,713 - 251,350 249,789

Total 243,702 10,713 - 254,415 254,166

Net gains/(losses) on
investments

(25,305

)

-

-

(25,305

)

240
NET
INCOME/(EXPENDITURE)

(83,215

)

793

-

(82,422

)

(85,856

)


RECONCILIATION OF
FUNDS

Total funds brought forward 455,540 33,440 278,167 767,147 853,003

TOTAL FUNDS CARRIED
FORWARD

372,325

34,233

278,167

684,725

767,147

WHITE HOUSE CANCER SUPPORT LIMITED (REGISTERED NUMBER: 07604847)

BALANCE SHEET
31ST MARCH 2020

2020 2019
Unrestricted Restricted Endowment Total Total
funds funds fund funds funds
Notes £    £    £    £    £   
FIXED ASSETS
Tangible assets 11 8,389 - 278,167 286,556 286,409

CURRENT ASSETS
Debtors 12 9,451 - - 9,451 3,676
Investments 13 318,022 - - 318,022 393,327
Cash at bank and in hand 57,462 34,233 - 91,695 93,856
384,935 34,233 - 419,168 490,859

CREDITORS
Amounts falling due within one
year

14

(20,999

)

-

-

(20,999

)

(10,121

)

NET CURRENT ASSETS 363,936 34,233 - 398,169 480,738

TOTAL ASSETS LESS
CURRENT LIABILITIES

372,325

34,233

278,167

684,725

767,147

NET ASSETS 372,325 34,233 278,167 684,725 767,147
FUNDS 15
Unrestricted funds 372,325 455,540
Restricted funds 34,233 33,440
Endowment funds 278,167 278,167
TOTAL FUNDS 684,725 767,147

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2020.


The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2020 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as
at the end of each financial year and of its surplus or deficit for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act
2006 relating to financial statements, so far as applicable to the charitable company.


WHITE HOUSE CANCER SUPPORT LIMITED (REGISTERED NUMBER: 07604847)

BALANCE SHEET - continued
31ST MARCH 2020

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.


The financial statements were approved by the Board of Trustees and authorised for issue on 30th July 2020 and were
signed on its behalf by:





T Beese - Trustee

WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2020

1. STATUTORY INFORMATION

White House Cancer Support Limited is a private company, limited by guarantee without share capital,
registered in England and Wales.

The presentation currency of the accounts is the Pound Sterling (£), rounded to the nearest pound.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been
prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement
of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial
Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)',
Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of
Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost
convention.

Financial reporting standard 102 - reduced disclosure exemptions
The charitable company has taken advantage of the following disclosure exemptions in preparing these financial
statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of
Ireland':

the requirements of Section 7 Statement of Cash Flows;
the requirement of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.41(b), 11.41(c), 11.41(e), 11.41(f),
11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and
12.29A;
the requirement of Section 33 Related Party Disclosures paragraph 33.7.

Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it
is probable that the income will be received and the amount can be measured reliably.

Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the
charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and
the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has
been classified under headings that aggregate all cost related to the category. Where costs cannot be directly
attributed to particular headings they have been allocated to activities on a basis consistent with the use of
resources.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful
life.


Non beneficial interest in property - No depreciation provided
Fixtures and fittings - 10% on cost
Computer equipment - 33% on cost

All fixed asset items above £500 are capitalised in the year of purchase.

The freehold property is not depreciated because it is a non beneficial interest as detailed in note 11.

Taxation
The charity is exempt from corporation tax on its charitable activities.

WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2020

2. ACCOUNTING POLICIES - continued

Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Designated funds are funds that the trustees have designated for a specific purpose.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions
arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Pension costs and other post-retirement benefits
The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable
company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

Debtors
Short term debtors are measured at transaction price, less any impairment.

Investments

Investments are shown at fair value.

Cash and cash equivalents

Cash and cash equivalents include deposits held on call at banks.

Debtors

Short term debtors are measured at transaction price, less any impairment.

Creditors

Short term creditors are measured at transaction price, less any impairment.
Liabilities in the accounts are for costs arising in the year that were unpaid at the balance sheet date.

Going Concern

The accounts are prepared on the going concern basis as the charity has sufficient funds to meet its liabilities for
more than the next 12 months.

3. DONATIONS AND LEGACIES
2020 2019
£    £   
Gifts and donations 105,142 72,021
Grants 57,730 46,210
162,872 118,231


WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2020

4. OTHER TRADING ACTIVITIES
2020 2019
£    £   
Fundraising events 9,196 19,302
Sundry Income 9,324 16,830
18,520 36,132

5. INVESTMENT INCOME
2020 2019
£    £   
Deposit account interest 30 78
Current asset investment income 15,876 13,629
15,906 13,707

6. SUPPORT COSTS
Governance
costs
£   
Social care 2,790

7. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

2020 2019
£    £   
Depreciation - owned assets 2,631 2,752
Independent examination 2,790 2,580

8. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31st March 2020 nor for the year ended
31st March 2019.


Trustees' expenses

During the year, no trustee received reimbursement of travel and other out of pocket expenses totalling £nil
incurred on the charity's behalf (2019 - £nil).


WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2020

9. STAFF COSTS
2020 2019
£    £   
Wages and salaries 136,661 150,352
Social security costs 7,751 8,569
Other pension costs 4,261 4,198
148,673 163,119

The average monthly number of employees during the year was as follows:

2020 2019
Paid employees 8 8

No employees received emoluments in excess of £60,000.

The total benefits received by key management personnel (including employer national insurance contributions)
during the year was £47,751 (2019 - £45,601).

During the year the charity received help from 54 volunteers for administration, transport, therapy and
counselling.

10. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted Restricted Endowment Total
funds funds fund funds
£    £    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 117,902 329 - 118,231

Other trading activities 36,132 - - 36,132
Investment income 13,707 - - 13,707
Total 167,741 329 - 168,070


EXPENDITURE ON
Raising funds 4,377 - - 4,377

Charitable activities
Social care 248,161 1,628 - 249,789

Total 252,538 1,628 - 254,166

Net gains on investments 240 - - 240
NET INCOME/(EXPENDITURE) (84,557 ) (1,299 ) - (85,856 )

Transfers between funds 3,000 (25,475 ) 22,475 -
Net movement in funds (81,557 ) (26,774 ) 22,475 (85,856 )

RECONCILIATION OF FUNDS

Total funds brought forward 537,097 60,214 255,692 853,003


WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2020

10. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted Restricted Endowment Total
funds funds fund funds
£    £    £    £   
TOTAL FUNDS CARRIED FORWARD 455,540 33,440 278,167 767,147

11. TANGIBLE FIXED ASSETS
Non
beneficial
interest Fixtures
in and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 1st April 2019 278,167 98,067 8,994 385,228
Additions - 2,778 - 2,778
At 31st March 2020 278,167 100,845 8,994 388,006
DEPRECIATION
At 1st April 2019 - 91,581 7,238 98,819
Charge for year - 1,671 960 2,631
At 31st March 2020 - 93,252 8,198 101,450
NET BOOK VALUE
At 31st March 2020 278,167 7,593 796 286,556
At 31st March 2019 278,167 6,486 1,756 286,409

The non beneficial interest in property represents the freehold property, The White House, 10 Ednam Road,
Dudley, West Midlands, DY1 1JX which is held in a charitable trust known as White House Cancer Support
Charitable Trust, with the company acting as sole corporate trustee (with trust corporation status).

12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2020 2019
£    £   
Prepayments and accrued income 9,451 3,676

13. CURRENT ASSET INVESTMENTS
2020 2019
£    £   
Listed investments 318,022 393,327

The investment is with Brewin Dolphin in a managed investment portfolio which is redeemable on demand. It is
stated at fair value at the year end.


WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2020

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2020 2019
£    £   
Accrued expenses 20,999 10,121

15. MOVEMENT IN FUNDS
Net
movement At
At 1/4/19 in funds 31/3/20
£    £    £   
Unrestricted funds
General fund 230,540 (83,215 ) 147,325
Services and property designated fund 225,000 - 225,000
455,540 (83,215 ) 372,325
Restricted funds
Carers fund 994 - 994
Equipment and refurbishment 165 1,200 1,365
Prostate Cancer Group 1,803 (100 ) 1,703
Rainbow Fund 24,246 (7,066 ) 17,180
Bowl Support Group 789 - 789
D Brettell Legacy 5,443 - 5,443
Wates - 6,759 6,759
33,440 793 34,233
Endowment funds
Property held as corporate trustee 278,167 - 278,167

TOTAL FUNDS 767,147 (82,422 ) 684,725

Net movement in funds, included in the above are as follows:

Incoming Resources Gains and Movement
resources expended losses in funds
£    £    £    £   
Unrestricted funds
General fund 185,792 (243,702 ) (25,305 ) (83,215 )

Restricted funds
Equipment and refurbishment 1,200 - - 1,200
Prostate Cancer Group - (100 ) - (100 )
Rainbow Fund 3,306 (10,372 ) - (7,066 )
Wates 7,000 (241 ) - 6,759
11,506 (10,713 ) - 793
TOTAL FUNDS 197,298 (254,415 ) (25,305 ) (82,422 )


WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2020

15. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Net Transfers
movement between At
At 1/4/18 in funds funds 31/3/19
£    £    £    £   
Unrestricted funds
General fund 312,097 (84,557 ) 3,000 230,540
Services and property designated fund 225,000 - - 225,000
537,097 (84,557 ) 3,000 455,540
Restricted funds
Carers fund 994 - - 994
Equipment and refurbishment 165 - - 165
Prostate Cancer Group 1,803 - - 1,803
Rainbow Fund 23,917 329 - 24,246
Sensory Garden 3,000 - (3,000 ) -
Bowl Support Group 789 - - 789
D Brettell Legacy 29,546 (1,628 ) (22,475 ) 5,443
60,214 (1,299 ) (25,475 ) 33,440
Endowment funds
Property held as corporate trustee 255,692 - 22,475 278,167

TOTAL FUNDS 853,003 (85,856 ) - 767,147

Comparative net movement in funds, included in the above are as follows:

Incoming Resources Gains and Movement
resources expended losses in funds
£    £    £    £   
Unrestricted funds
General fund 167,741 (252,538 ) 240 (84,557 )

Restricted funds
Rainbow Fund 329 - - 329
D Brettell Legacy - (1,628 ) - (1,628 )
329 (1,628 ) - (1,299 )
TOTAL FUNDS 168,070 (254,166 ) 240 (85,856 )

WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2020

15. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

Net Transfers
movement between At
At 1/4/18 in funds funds 31/3/20
£    £    £    £   
Unrestricted funds
General fund 312,097 (167,772 ) 3,000 147,325
Services and property designated fund 225,000 - - 225,000
537,097 (167,772 ) 3,000 372,325
Restricted funds
Carers fund 994 - - 994
Equipment and refurbishment 165 1,200 - 1,365
Prostate Cancer Group 1,803 (100 ) - 1,703
Rainbow Fund 23,917 (6,737 ) - 17,180
Sensory Garden 3,000 - (3,000 ) -
Bowl Support Group 789 - - 789
D Brettell Legacy 29,546 (1,628 ) (22,475 ) 5,443
Wates - 6,759 - 6,759
60,214 (506 ) (25,475 ) 34,233
Endowment funds
Property held as corporate trustee 255,692 - 22,475 278,167

TOTAL FUNDS 853,003 (168,278 ) - 684,725

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are
as follows:

Incoming Resources Gains and Movement
resources expended losses in funds
£    £    £    £   
Unrestricted funds
General fund 353,533 (496,240 ) (25,065 ) (167,772 )

Restricted funds
Equipment and refurbishment 1,200 - - 1,200
Prostate Cancer Group - (100 ) - (100 )
Rainbow Fund 3,635 (10,372 ) - (6,737 )
D Brettell Legacy - (1,628 ) - (1,628 )
Wates 7,000 (241 ) - 6,759
11,835 (12,341 ) - (506 )
TOTAL FUNDS 365,368 (508,581 ) (25,065 ) (168,278 )

Description of restricted funds

The carers fund consists of a grant from Dudley MBC to provide charity carers with social events.

The equipment and refurbishment fund consists of various grants and donations received to buy equipment and
refurbish the premises.


WHITE HOUSE CANCER SUPPORT LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2020

15. MOVEMENT IN FUNDS - continued

The prostate cancer group fund consists of donations received for the prostate cancer group.

The rainbow fund consists of donations from the rainbow breast reconstruction group and others.

The sensory garden fund consists of a donation to create a therapeutic garden.

The bladder, urology, bowl and strome cancer group fund consists of donations received for the BUBS cancer
group.

The D Brettell legacy fund consists of a bequest for medical or building needs.

The Wates fund consists of a donation to fund new project costs.


Endowment funds

This represents the charitable company's non beneficial interest in the freehold property, The White House, 10
Ednam Road, Dudley, West Midlands, DY1 1JX, which is held in a charitable trust known as White House
Cancer Support Charitable Trust, with the company acting as sole corporate trustee (with trust corporation
status).

Designated funds

The trustees have designated funds to enable the charity to develop, improve or expand its range of services
and/or its premises as part of the Strategic Plan.

16. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31st March 2020.